Abstract
In the last decade novel therapeutic approaches for the treatment of cancer have been proposed: inhibitors of serine/threonine and tyrosine kinases, angiogenesis inhibitors, gene therapy approaches and others. In some cases the clinical trials have confirmed the efficacy of these approaches. Here, we will review the discovered molecular targets for the treatment of testicular germ cell tumors.
Keywords: Testis, testicular cancer, Aurora kinases, tyrosine kinases, angiogenesis, kinases inhibitors, gene therapy
Mini-Reviews in Medicinal Chemistry
Title: Molecular Targets for the Treatment of Testicular Germ Cell Tumors
Volume: 7 Issue: 7
Author(s): Paolo Chieffi and Paolo Chieffi
Affiliation:
Keywords: Testis, testicular cancer, Aurora kinases, tyrosine kinases, angiogenesis, kinases inhibitors, gene therapy
Abstract: In the last decade novel therapeutic approaches for the treatment of cancer have been proposed: inhibitors of serine/threonine and tyrosine kinases, angiogenesis inhibitors, gene therapy approaches and others. In some cases the clinical trials have confirmed the efficacy of these approaches. Here, we will review the discovered molecular targets for the treatment of testicular germ cell tumors.
Export Options
About this article
Cite this article as:
Paolo Chieffi and Chieffi Paolo, Molecular Targets for the Treatment of Testicular Germ Cell Tumors, Mini-Reviews in Medicinal Chemistry 2007; 7 (7) . https://dx.doi.org/10.2174/138955707781024472
DOI https://dx.doi.org/10.2174/138955707781024472 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Engagement of Renin-Angiotensin System in Prostate Cancer
Current Cancer Drug Targets Deaza Analogs of Folic Acid as Antitumor Agents
Current Pharmaceutical Design New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Non-Replicating Viral Vector-Based AIDS Vaccines: Interplay Between Viral Vectors and the Immune System
Current HIV Research Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
Current Molecular Medicine (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside Transporters
Current Drug Metabolism Seeking the 5th Base of DNA Using Chromatographic Methods of Analysis
Current Organic Chemistry New Prognostic Markers and Potential Therapeutic Targets in Human Testicular Germ Cell Tumors
Current Medicinal Chemistry The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma
Anti-Cancer Agents in Medicinal Chemistry Higher Placental Anti-Inflammatory IL-10 Cytokine Expression in HIV-1 Infected Women Receiving Longer Zidovudine Prophylaxis Associated with Nevirapine
Current HIV Research Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication
Current Drug Metabolism The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
Current Cancer Drug Targets Gynecomastia in Infants, Children, and Adolescents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition
Current Medicinal Chemistry Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Mini-Reviews in Medicinal Chemistry ATP-Binding Cassette Efflux Transporters in Human Placenta
Current Pharmaceutical Biotechnology